Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 9 | 2020 | 313 | 3.420 |
Why?
|
| Prenatal Care | 7 | 2024 | 347 | 3.300 |
Why?
|
| Pregnancy Complications, Infectious | 12 | 2023 | 432 | 3.030 |
Why?
|
| Streptococcus agalactiae | 8 | 2020 | 113 | 2.630 |
Why?
|
| Obstetrics | 5 | 2022 | 244 | 2.370 |
Why?
|
| Gynecology | 4 | 2022 | 235 | 2.310 |
Why?
|
| Antibiotic Prophylaxis | 5 | 2020 | 214 | 1.890 |
Why?
|
| Pregnancy | 43 | 2024 | 8105 | 1.680 |
Why?
|
| Chorioamnionitis | 2 | 2021 | 42 | 1.550 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2021 | 59 | 1.500 |
Why?
|
| Version, Fetal | 2 | 2020 | 7 | 1.480 |
Why?
|
| Social Media | 2 | 2022 | 211 | 1.100 |
Why?
|
| Cesarean Section | 7 | 2023 | 401 | 1.000 |
Why?
|
| Pregnancy Trimester, Third | 4 | 2020 | 117 | 0.920 |
Why?
|
| Labor Stage, Second | 1 | 2023 | 20 | 0.870 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 324 | 0.870 |
Why?
|
| Delphi Technique | 2 | 2024 | 275 | 0.870 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2020 | 24 | 0.840 |
Why?
|
| Neonatal Sepsis | 1 | 2022 | 29 | 0.810 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2022 | 28 | 0.810 |
Why?
|
| Endometritis | 1 | 2021 | 11 | 0.800 |
Why?
|
| Breech Presentation | 2 | 2020 | 21 | 0.780 |
Why?
|
| Penicillins | 2 | 2020 | 166 | 0.780 |
Why?
|
| Surgical Mesh | 1 | 2022 | 212 | 0.730 |
Why?
|
| Peripartum Period | 1 | 2020 | 34 | 0.710 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 638 | 0.700 |
Why?
|
| Prenatal Diagnosis | 2 | 2018 | 609 | 0.680 |
Why?
|
| Vulvar Lichen Sclerosus | 1 | 2019 | 7 | 0.680 |
Why?
|
| Sexism | 1 | 2019 | 54 | 0.670 |
Why?
|
| Genitalia, Female | 1 | 2019 | 85 | 0.640 |
Why?
|
| Liability, Legal | 1 | 2018 | 48 | 0.630 |
Why?
|
| Drug Hypersensitivity | 1 | 2020 | 134 | 0.630 |
Why?
|
| Lacerations | 1 | 2019 | 35 | 0.630 |
Why?
|
| Fetal Death | 1 | 2018 | 134 | 0.620 |
Why?
|
| Venous Thromboembolism | 2 | 2020 | 376 | 0.620 |
Why?
|
| Stillbirth | 1 | 2018 | 86 | 0.610 |
Why?
|
| Platelet Count | 1 | 2019 | 491 | 0.610 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2019 | 143 | 0.600 |
Why?
|
| Female | 51 | 2024 | 149288 | 0.590 |
Why?
|
| Cervix Uteri | 2 | 2017 | 252 | 0.590 |
Why?
|
| Delivery, Obstetric | 3 | 2022 | 259 | 0.570 |
Why?
|
| Patient Preference | 1 | 2019 | 225 | 0.570 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 3176 | 0.570 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2020 | 239 | 0.570 |
Why?
|
| Parturition | 1 | 2017 | 64 | 0.560 |
Why?
|
| Bias | 1 | 2017 | 214 | 0.530 |
Why?
|
| Obstetric Labor Complications | 3 | 2007 | 98 | 0.530 |
Why?
|
| Humans | 62 | 2024 | 272087 | 0.520 |
Why?
|
| Infant, Newborn | 13 | 2023 | 8612 | 0.510 |
Why?
|
| Carrier State | 1 | 2015 | 86 | 0.510 |
Why?
|
| Betacoronavirus | 1 | 2020 | 522 | 0.490 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 487 | 0.480 |
Why?
|
| Pandemics | 2 | 2022 | 1607 | 0.470 |
Why?
|
| Telemedicine | 2 | 2021 | 549 | 0.470 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 633 | 0.410 |
Why?
|
| Pregnancy Outcome | 6 | 2024 | 681 | 0.410 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 709 | 0.410 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 2681 | 0.380 |
Why?
|
| Physicians | 1 | 2019 | 870 | 0.380 |
Why?
|
| Internship and Residency | 1 | 2022 | 1441 | 0.360 |
Why?
|
| Cerclage, Cervical | 2 | 2007 | 11 | 0.360 |
Why?
|
| Pregnancy Complications | 4 | 2021 | 560 | 0.350 |
Why?
|
| United States | 7 | 2024 | 16066 | 0.340 |
Why?
|
| Biomedical Research | 1 | 2017 | 802 | 0.340 |
Why?
|
| Erythromycin | 2 | 2021 | 23 | 0.330 |
Why?
|
| Sepsis | 1 | 2014 | 689 | 0.320 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 4400 | 0.320 |
Why?
|
| Gestational Age | 3 | 2023 | 1153 | 0.300 |
Why?
|
| Hospitals, Community | 2 | 2007 | 81 | 0.290 |
Why?
|
| Anticoagulants | 2 | 2020 | 792 | 0.290 |
Why?
|
| Constriction, Pathologic | 2 | 2007 | 324 | 0.280 |
Why?
|
| Uterus | 2 | 2007 | 815 | 0.270 |
Why?
|
| Hospitals, University | 1 | 2007 | 220 | 0.270 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 2006 | 9 | 0.270 |
Why?
|
| Prothrombin Time | 1 | 2006 | 42 | 0.270 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 968 | 0.260 |
Why?
|
| Genetic Testing | 1 | 2014 | 1699 | 0.260 |
Why?
|
| Fluconazole | 1 | 2006 | 109 | 0.250 |
Why?
|
| Cerebral Palsy | 1 | 2007 | 85 | 0.250 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 1997 | 113 | 0.250 |
Why?
|
| Warfarin | 1 | 2006 | 152 | 0.240 |
Why?
|
| Retrospective Studies | 14 | 2023 | 39831 | 0.230 |
Why?
|
| Fetal Viability | 1 | 2023 | 31 | 0.220 |
Why?
|
| Appointments and Schedules | 1 | 2024 | 97 | 0.220 |
Why?
|
| Labor Stage, First | 1 | 2023 | 7 | 0.220 |
Why?
|
| Vagina | 3 | 2021 | 331 | 0.220 |
Why?
|
| Parity | 1 | 2023 | 136 | 0.210 |
Why?
|
| Adult | 18 | 2024 | 81933 | 0.210 |
Why?
|
| Postpartum Hemorrhage | 1 | 2022 | 89 | 0.190 |
Why?
|
| China | 1 | 2023 | 645 | 0.190 |
Why?
|
| Azithromycin | 1 | 2021 | 79 | 0.190 |
Why?
|
| Surgical Instruments | 1 | 2021 | 138 | 0.190 |
Why?
|
| Decision Making | 2 | 2020 | 1247 | 0.190 |
Why?
|
| Pregnancy, Multiple | 3 | 2014 | 48 | 0.190 |
Why?
|
| Urinary Retention | 1 | 2021 | 22 | 0.190 |
Why?
|
| Desogestrel | 1 | 2020 | 6 | 0.180 |
Why?
|
| Morbidity | 1 | 2021 | 405 | 0.180 |
Why?
|
| Simulation Training | 1 | 2022 | 162 | 0.180 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 215 | 0.180 |
Why?
|
| Contraceptive Agents, Female | 1 | 2020 | 36 | 0.170 |
Why?
|
| Antifungal Agents | 1 | 2006 | 877 | 0.170 |
Why?
|
| Contraception | 1 | 2020 | 63 | 0.170 |
Why?
|
| Uterine Contraction | 2 | 1997 | 32 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 2430 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2023 | 348 | 0.170 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2019 | 47 | 0.170 |
Why?
|
| Birth Injuries | 1 | 1999 | 27 | 0.170 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 107 | 0.160 |
Why?
|
| Consensus | 1 | 2024 | 1116 | 0.160 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 64 | 0.160 |
Why?
|
| Twins | 2 | 2014 | 78 | 0.160 |
Why?
|
| Hysterectomy | 1 | 2022 | 649 | 0.160 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 657 | 0.150 |
Why?
|
| Maternal Age | 1 | 2018 | 147 | 0.150 |
Why?
|
| Endometriosis | 1 | 2021 | 235 | 0.150 |
Why?
|
| Choice Behavior | 1 | 2019 | 206 | 0.150 |
Why?
|
| Abruptio Placentae | 1 | 1997 | 18 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 489 | 0.150 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 378 | 0.150 |
Why?
|
| Probability | 1 | 2018 | 887 | 0.140 |
Why?
|
| Dystocia | 1 | 1997 | 24 | 0.140 |
Why?
|
| Reference Values | 1 | 2019 | 1155 | 0.140 |
Why?
|
| Betamethasone | 1 | 1996 | 17 | 0.140 |
Why?
|
| Rectus Abdominis | 1 | 1997 | 90 | 0.140 |
Why?
|
| Anesthesia | 1 | 2020 | 306 | 0.140 |
Why?
|
| Terbutaline | 1 | 1996 | 30 | 0.140 |
Why?
|
| Tocolytic Agents | 1 | 1996 | 12 | 0.140 |
Why?
|
| Muscular Diseases | 1 | 1997 | 163 | 0.140 |
Why?
|
| Vomiting | 1 | 2018 | 361 | 0.130 |
Why?
|
| Hematoma | 1 | 1997 | 159 | 0.130 |
Why?
|
| Chlamydia trachomatis | 1 | 1995 | 29 | 0.130 |
Why?
|
| Nausea | 1 | 2018 | 540 | 0.130 |
Why?
|
| Gastroplasty | 1 | 1995 | 21 | 0.130 |
Why?
|
| Coronary Aneurysm | 1 | 1996 | 35 | 0.130 |
Why?
|
| Diseases in Twins | 1 | 1996 | 109 | 0.130 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1996 | 43 | 0.130 |
Why?
|
| Obstetric Labor, Premature | 1 | 1996 | 85 | 0.130 |
Why?
|
| Chlamydia Infections | 1 | 1995 | 48 | 0.130 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1996 | 89 | 0.130 |
Why?
|
| Heart Diseases | 2 | 2019 | 740 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2020 | 592 | 0.130 |
Why?
|
| Amoxicillin | 1 | 1995 | 123 | 0.120 |
Why?
|
| Term Birth | 1 | 2014 | 34 | 0.120 |
Why?
|
| Heart Transplantation | 2 | 2012 | 905 | 0.120 |
Why?
|
| Herpes Genitalis | 1 | 1994 | 16 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 1060 | 0.120 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1994 | 40 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 878 | 0.120 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 529 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 916 | 0.120 |
Why?
|
| Thromboembolism | 1 | 1995 | 153 | 0.120 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1994 | 139 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2015 | 2335 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2022 | 5693 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2020 | 1349 | 0.110 |
Why?
|
| Aneuploidy | 1 | 2014 | 377 | 0.110 |
Why?
|
| Fibrinolytic Agents | 1 | 1995 | 303 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1995 | 349 | 0.110 |
Why?
|
| Heart-Assist Devices | 2 | 2012 | 1056 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 1996 | 622 | 0.100 |
Why?
|
| Bacteriological Techniques | 1 | 2013 | 123 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2019 | 6236 | 0.100 |
Why?
|
| Heart Failure, Systolic | 1 | 2012 | 34 | 0.100 |
Why?
|
| Heart Atria | 1 | 1994 | 357 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2021 | 13410 | 0.100 |
Why?
|
| Forecasting | 1 | 2014 | 706 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 1994 | 366 | 0.100 |
Why?
|
| Dilatation | 2 | 2023 | 87 | 0.100 |
Why?
|
| Age Factors | 2 | 2019 | 5526 | 0.100 |
Why?
|
| Risk Factors | 4 | 2021 | 18051 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2022 | 33909 | 0.090 |
Why?
|
| Middle Aged | 5 | 2021 | 90460 | 0.090 |
Why?
|
| Postpartum Period | 2 | 2023 | 261 | 0.090 |
Why?
|
| Recurrence | 2 | 2015 | 4887 | 0.090 |
Why?
|
| Quality of Life | 1 | 2024 | 4755 | 0.080 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 226 | 0.080 |
Why?
|
| Myocarditis | 1 | 2011 | 194 | 0.080 |
Why?
|
| Costs and Cost Analysis | 1 | 2009 | 311 | 0.080 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 161 | 0.080 |
Why?
|
| Thrombosis | 1 | 1994 | 755 | 0.080 |
Why?
|
| Cervical Length Measurement | 1 | 2007 | 3 | 0.080 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2007 | 7 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 1996 | 1304 | 0.070 |
Why?
|
| Mass Screening | 1 | 2015 | 1548 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 5935 | 0.070 |
Why?
|
| Elective Surgical Procedures | 1 | 2007 | 249 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2009 | 605 | 0.060 |
Why?
|
| Young Adult | 2 | 2020 | 22142 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 4900 | 0.050 |
Why?
|
| Adolescent | 3 | 2019 | 32730 | 0.050 |
Why?
|
| Michigan | 1 | 2021 | 60 | 0.050 |
Why?
|
| Texas | 2 | 2007 | 6440 | 0.050 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 247 | 0.050 |
Why?
|
| Pelvic Pain | 1 | 2021 | 47 | 0.050 |
Why?
|
| Logistic Models | 2 | 2020 | 3469 | 0.050 |
Why?
|
| Curettage | 1 | 2020 | 22 | 0.050 |
Why?
|
| Drug Implants | 1 | 2020 | 53 | 0.040 |
Why?
|
| Prevalence | 1 | 2008 | 3427 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 51 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2020 | 51 | 0.040 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 118 | 0.040 |
Why?
|
| Birth Weight | 1 | 2021 | 352 | 0.040 |
Why?
|
| Patient Selection | 1 | 2007 | 2045 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 1782 | 0.040 |
Why?
|
| Male | 5 | 2019 | 129088 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 474 | 0.040 |
Why?
|
| Abdomen, Acute | 1 | 1997 | 38 | 0.040 |
Why?
|
| Trial of Labor | 1 | 1997 | 22 | 0.040 |
Why?
|
| Aged | 2 | 2021 | 73517 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2021 | 1017 | 0.030 |
Why?
|
| Incidence | 2 | 1997 | 5864 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 914 | 0.030 |
Why?
|
| Contraindications | 1 | 1996 | 155 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2023 | 1943 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1997 | 758 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1995 | 92 | 0.030 |
Why?
|
| Arginine | 1 | 2018 | 510 | 0.030 |
Why?
|
| Cesarean Section, Repeat | 1 | 1994 | 7 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 1995 | 234 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 2259 | 0.030 |
Why?
|
| History, 20th Century | 1 | 1995 | 550 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 2290 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 1995 | 238 | 0.030 |
Why?
|
| Time Factors | 1 | 2006 | 13139 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 1459 | 0.020 |
Why?
|
| Body Surface Area | 1 | 2011 | 40 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1995 | 747 | 0.020 |
Why?
|
| Reoperation | 1 | 1995 | 1391 | 0.020 |
Why?
|
| Infant, Premature | 1 | 1996 | 828 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 420 | 0.020 |
Why?
|
| Rectum | 1 | 2013 | 479 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2012 | 265 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2023 | 9500 | 0.020 |
Why?
|
| North America | 1 | 2011 | 341 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2012 | 663 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 6885 | 0.020 |
Why?
|
| Obesity | 1 | 2021 | 2958 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 2011 | 239 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 560 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1995 | 3856 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 2355 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2012 | 17056 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 5196 | 0.010 |
Why?
|
| Premature Birth | 1 | 2007 | 405 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6270 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 6210 | 0.010 |
Why?
|
| Child | 2 | 2012 | 30559 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12534 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 13970 | 0.010 |
Why?
|